Anish Chitra

Stealth Strategies for Cancer Nanomedicine: A Review of Immune Evasion and Tumor Targeting

Nanocarrier platforms can improve cancer therapy through enhanced selectivity and reduced systemic toxicity. Yet mononuclear phagocyte system (MPS) clearance sharply limits delivery; in preclinical models, often less than 1% of the injected dose reaches tumors. Surface-engineering strategies that let nanocarriers evade...